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Procedures for the ethical review
of public health surveillance protocols
INTRODUCTION
The distinction between “research” and “intervention” 
involving humans is of crucial importance. Regulations 
introduced in recent decades, for instance, require that 
research studies with human subjects be authorised 
only after a competent ethics committee has approved 
them. Medical interventions, treatments and current 
practices, on the other hand, generally require no such 
authorisation [1]. A clear definition of the different pro-
cedures is thus essential.
Many regulations adopt the definitions and distinc-
tions stated in the “Belmont Report” of the National 
Commission for the Protection of Human Subjects 
[2]. The Federal Policy for the Protection of Human 
Research Subjects (informally known as the “Common 
Rule”) states that “research mens a systematic inves-
tigation, including research development, testing and 
evaluation, designed to develop or contribute to gener-
alizable knowledge” [3].
The World Health Organization (WHO), in its Reso-
lution WHA58.3, defines surveillance as “the system-
atic ongoing collection, collation and analysis of data 
for public health purposes and the timely dissemination 
of public health information for assessment and public 
health response as necessary” [4]. Gostin defines it as 
“The public health practice of continual watchfulness 
over the distribution and trends of risk factors, injury, 
and disease in the population through the system-
atic collection, analysis, and interpretation of selected 
health data for use in the planning, implementation, 
and evaluation of public health practice” [5]. The de-
bate as to whether public health surveillance should be 
considered as “research” is still open [6].
PUBLIC HEALTH SURVEILLANCE 
AS RESEARCH
If we adopt the definition of research used in the Bel-
mont Report, i.e. that it is “designed to develop or con-
tribute to generalizable knowledge”, we must recognise 
that a large portion of surveillance falls within it. On a 
more general level we could even say that everything 
to do with public health is research: according to the 
Oxford textbook of public health one of the core func-
tions of a public health system is “to gather health in-
formation and deploy those data for the welfare of the 
community” [7].
If we agree with the WHO that “All research with 
human participants is presumptively subject to REC 
(Research Ethics Committee) oversight” [8] we must 
deduce that public health surveillance must be assessed 
and approved by an REC before it can proceed. In 
other words, recourse to RECs becomes indispensable. 
At most, a simplified procedure to accelerate matters 
could be contemplated. In fact the WHO states else-
where that “Specific categories of research may be ex-
empted from REC review or subject to expedited re-
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view” [8] and, more specifically, “Protocols involving 
no more than minimal risk and burden to research par-
ticipants may be reviewed on an expedited basis by one 
or more members (rather than the full committee), if 
the REC has established written procedures permitting 
such a procedure” [9].
Thus a debate focused on defining “research” and 
“surveillance” is unlikely to conclude that “surveillance” 
is not “research” and is thus exempt from even a simpli-
fied procedure of referral to an REC.
FROM A DISTINCTION BETWEEN 
RESEARCH AND INTERVENTION 
TO RISK ASSESSMENT
In the particular matter of surveillance it would be 
helpful to shift the focus from forging a distinction be-
tween research and intervention to weighing the risks 
associated with each procedure, particularly the type of 
risk, the probability of its occurrence and its magnitude.
“Research involving humans should be initiated only 
if the anticipated benefit(s) for the individual research 
subject and society clearly outweigh the risks. Although 
the benefit of the results of the trial to science and so-
ciety should be taken into account, the most important 
considerations are those related to the rights, safety, 
and well being of the research subjects” [10]. There may 
nonetheless arise specific situations in which research 
may be legitimate even in the absence of direct ben-
efit. This is generally acceptable so long as the level of 
so-called “minimal risk” is not exceeded. According to 
the Department of Health and Human Services a risk 
is “minimal” if the “probability and magnitude of harm 
or discomfort anticipated in the research are not greater 
in and of themselves than those ordinarily encountered 
in daily life or during the performance of routine physi-
cal or physiological examinations or tests” [11]. The risks 
involved in public health surveillance do not often exceed 
the “minimal” level, or even the recently proposed level of 
“de minimis risk”. According to its proponents, “de mini-
mis risk” is “a subcategory of minimal risk that would ap-
ply to studies involving only negligible physical risk where 
nothing dangerous is done to the body and no likely or 
significant social or psychological harms are foreseen. Ob-
taining informed consent should not be an absolute re-
quirement for studies that involve only this subcategory, 
vanishingly small level of de minimis risk” [12].
MINIMAL RISK AND THE PROTECTION 
OF PERSONAL DATA
Public health surveillance poses a number of ethical 
problems [13], most of which concern the protection of 
personal data [14]. As noted in the Canadian Institutes 
of Health Research (Institute of Population and Public 
Health), “the problems involved in managing the data 
used as inputs to surveillance plans have received on-
going attention in the literature” [15]. However, while 
recent decades have seen increasing attention to the pro-
tection of personal data in the research and public health 
settings, more recent proposals “suggest the regulatory 
pendulum is taking a swing to the permissive” [16]. The 
Institute of Medicine, for instance,  is now recommend-
ing that all research be exempted from the Health Insur-
ance Portability and Accountability Act (HIPAA) Pri-
vacy Rule and that all “information-based” research be 
freed from informed consent requirements [17].
CONCLUSIONS: SIMPLIFICATION 
OF THE ASSESSMENT PROCEDURE
In the case of public health surveillance, when no pro-
cedures are envisaged that directly involve individuals 
the interests of the community at large may, in specific 
circumstances, override the requirement to protect per-
sonal data. This is not the same as adopting a utilitar-
ian ethical stance, but rather an acknowledgement that 
there are different kinds of risks to the individual, and 
that they are not all equally significant. It is therefore to 
be hoped that procedures for the authorisation of pub-
lic health surveillance studies can be kept in proportion 
to the risks involved without becoming an obstacle to 
their completion.
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